Front Page VSPN Message Boards Chat Library Continual Education Search MyVSPN - Coming Soon Help Frequently Asked Questions Send us Feedback! Go to VIN Industry Partners Go to VetQuest Go to Veterinary Partner Go to Y2Spay
 
Menu bar   Go to the VIN.com Portal
 

ABSTRACT OF THE WEEK

The Veterinary record
Volume 180 | Issue 21 (May 2017)

Chemotherapy drug handling in first opinion small animal veterinary practices in the United Kingdom: results of a questionnaire survey.

Vet Rec. May 2017;180(21):518.
E G Edery1
1 Pride Veterinary Centre, Riverside Road, Derby DE24 8HX, UK.
British Veterinary Association.

Abstract

To investigate how first opinion small animal veterinary surgeons in the UK handled chemotherapeutic agents, a questionnaire was distributed at the 2014 British Small Animal Veterinary Association congress and by internet. Chemotherapy was regularly offered by 70.4 per cent of the respondents. Gold standards defined according to available guidelines for safe handling of antineoplastic drugs were poorly followed by general practitioners with only 2 per cent of respondents complying with all of them. Dedicated facilities for preparation and administration of cytotoxic drugs were variably available among participants. The level of training of staff indirectly involved in handling chemotherapy was appropriate in less than 50 per cent of practices. No association was found between demographic characteristics of the sampled population and the decision to perform chemotherapy. The results of this study raise concerns about the safety of the veterinary staff in first opinion practices involved in handling chemotherapy.

Companion Notes

Questionnaire on chemotherapy drug handling in first opinion small animal practices in the UK

    

Introduction on chemotherapy drug handling

- chemotherapy offered more and more by first opinion UK practitioners

- chemotherapeutic cytotoxic agents in human medicine:

- have many late adverse effects

- 1st evidence came from childhood cancer survivors

- they developed second malignancies

- particularly leukemias and myelodysplasias

- other adverse effects include the following:

- mutagenicity

- carcinogenicity

- teratogenicity

- adverse reproductive effects

- acute side effects reported as well

- in ’79 a new field of research on occupational hazards was started

- including hazards associated with handling chemotherapeutic agents

- numerous studies have since confirmed occupational exposure

- and various routes of exposure by environment monitoring

(air and surface sampling)

- many guidelines issued in last 30 years

- in veterinary oncology

- little research on occupational hazards in veterinary oncology

- in the UK

- 2 acts form a legal frame for employers to ensure workplace safety

- Health and Safety at Work Act (1974)

- Management of Health and Safety at Work (1999)

- cytotoxic drugs are hazardous substances

- fall under Control of Substances Hazardous to Health regulations

- Royal College of Veterinary Surgeons provides guidance

- in its Code of Professional

- it’s unknown if guidelines are followed in the UK

    

Study design

- study population:

- 71 respondents to questionnaire on handling of antineoplastic drugs

- veterinary surgeon, 66

- veterinary nurse, 5

- woman, 54

- procedure:

- questionnaire

- distributed at 2014 British Small Animal Veterinary Association congress

- distributed via internet

- survey answers compared with guidelines on handling chemotherapeutic agents

- those issued by European College of Veterinary Internal Medicine (2007)

(ECVIM. (2007) Preventing occupational and environmental exposure to

cytotoxic drugs in veterinary medicine. In European College of

Veterinary Internal Medicine-Companion Animals)

- set as highest (gold) standard

    

Results

- chemotherapy regularly offered by 70.4% of the 71 respondents

- 2% complied with gold standards for safe handling of antineoplastic drugs

(standards defined according to available guidelines)

- standards were poorly followed by general practitioners

- dedicated room for preparation of antineoplastics, 22% of responders

- ventilated cabinet, 4%

- antineoplastics predominantly prepared by veterinarians, 52%

- veterinary nurses also involved, 10%

- custom-prepared chemotherapy for individual patients, 24%

- from a specialist pharmacy

- infusion materials

- standard needles and infusion kits, 60%

- infusion kits with Luer lock fitting, 28%

- closed systems, 14%

- regular gloves, 66% (2% used no gloves)

- chemotherapy-specific gloves, 30%

- protective gowns

- disposable protective clothing not tested for handling cytotoxics, 52%

- standard of care, 26%

- non-disposable gowns, 12%

- no protective gown, 6% (4% did not provide details)

- face protection

- surgical masks, 50%

- only eye protection, 36%

- FFP2 or 3 respirator masks, 10%

- no mask at all, 26%

- conditions of administration

- in designated treatment room, 68%

- kennels, 16%

- in consultation room in absence of owner, 14%

- in consultation room with owner, 4%

- cytotoxic spill kit available, 48%

- purple flagged containers for disposal of cytotoxic agents, 90%

- specific training for other staff members involved, 44%

- including the following:

- informal in-house training, 38%

- training at veterinary nursing colleges, 20%

- information for owners

- verbal information, 54%

- written instructions, 44%

- did not inform clients of the potential hazards, 2%

- level of staff training indirectly involved in handling chemotherapy

- appropriate in under 50% of practices

- demographics of the respondents not associated with decision to do chemotherapy

- number of chemotherapy sessions per year

- 66% performed less than 10

- 20% performed 11-20

- 10% performed and 21-40

- most commonly cited drugs (cited by 6 or more respondents)

- vincristine, 40

- cyclophosphamide, 19

- doxorubicin, 15

- vinblastine, 7

- L-asparaginase, 6

    

“Of concern, more than 50 per cent reported that other members of staff involved in the handling of chemotherapy patients and cytotoxic waste had not been specifically trained.”

Keywords
Chemotherapy; Companion animals; Oncology; Public health; Surveys;

Article Tools:
   Medline
   Email to me

Archives Highlights:
Feline blood donation: Description and adverse reactions from 29 201 donation events between 2019 and 2023.
Adverse reactions were uncommon (0.29%, 2.88/1000 donor events) and most commonly were cardiorespiratory (0.08%, 0.75/1000 donor events) or behavioral (0.06%, 0.62/1000 donor events). The only risk factor significantly associated with adverse reactions was conscious donation, with conscious donors 4.4 times more likely to have an adverse reaction.
Clinical characterization of a novel episodic ataxia in young working Cocker Spaniels.
The mean age at clinical onset was 4 months. Signs were acute and included episodic body swaying, titubation, cerebellar ataxia, wide-base stance, and hypermetria, all while mentation remained unaltered. Duration of episodes ranged from 30 minutes up to 24 hours, and their frequency varied from weekly to once every 5 months.
Computed tomography findings of nasal cryptococcosis in Australia (2008-2020): 12 dogs and 9 cats.
Dogs were more likely to have a nasal mass, whereas cats were more likely to have a nasopharyngeal mass. Cribriform plate lysis was common in dogs, but not observed in cats. Sinonasal osteolysis was a common feature in both species. Mandibular lymph nodes were commonly enlarged in dogs, whereas in cats, the retropharyngeal lymph nodes were more likely enlarged.
National survey reveals elastic price sensitivity for select equine veterinary services.
Willingness-to-pay questions were presented with a payment card approach and addressed 3 common services: annual spring vaccinations, lameness examinations, and emergency colic surgeries. In a payment card approach, respondents choose from among preselected values. Respondents were asked to choose the maximum amount they would be willing to pay for each service.
A review of prevention and management of castration complications
Despite castration being one of the most frequently performed elective equine surgical procedures, complication rates are high and range from severe life-threatening conditions to mild complications that are of no consequence to the horse. This article will briefly review strategies to prevent complications and surgical castration techniques before reviewing, in-depth, the following complications: excessive scrotal swelling and seroma formation, scrotal infection, septic funiculitis, septic peritonitis, haemorrhage, evisceration, omental prolapse, pyrexia, tetanus, penile trauma, hydrocele, signs of colic, and continued stallion-like behaviour.

Back Print Save Bookmark in my Browser Email this article to me. Top of Page. VSPN AOW : Chemotherapy drug handlin...
Contact Us